Condition: Prostatic Neoplasms, Neoplasm Metastasis

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT02138721

Sponsor: University Hospital, Ghent

Eligibility:

• Age: minimum 18 Years maximum 85 Years
• Gender: Male

Inclusion Criteria:

• Diagnosis of prostate adenocarcinoma, confirmed by histology
• Newly diagnosis of metastatic disease (stage TanyNanyM+)
• Life expectancy ≥2y based on comorbid conditions, WHO performance status 0-2
• Written informed consent, male ≥18yo
• Willing and expected to comply with study protocol and follow-up schedule
• Multidisciplinary Oncologic Consultation (MOC) approval

Exclusion Criteria:

• Previous local or systemic treatment for prostate cancer
• Metastatic brain disease, leptomeningeal disease or imminent spinal cord compression
• Symptoms clearly related to metastatic lesions
• Any other previous or current (malignant) disease which, in the judgment of the responsible physician, is likely to interfere with LoMP treatment or assessment

View trial on ClinicalTrials.gov